Health Trials

Cryopyrin-associated Periodic Syndromes (CAPS)

2

Review clinical trials related to Cryopyrin-associated Periodic Syndromes (CAPS). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Ilaris NIS in Korea

This is a study to evaluate safety and effectiveness of Ilaris in adult and pediatric patients receiving the drug in a clinical setting for any of the following indications, Hereditary Periodic Fever Syndromes, Cryopyrin-associated periodic syndromes (CAPS), colchicine resistance familial Mediterranean fever (crFMF), TNF receptor associated periodic syndrome (TRAPS), Hyper-IgD syndrome / Mevalonate kinase deficiency (HIDS/MKD) or Systemic juvenile idiopathic arthritis (sJIA).

Participants needed: 25
Trial details
Age: 2-100Biological sex: AllType: ObservationalSponsor: Novartis PharmaceuticalsUpdated: May 19, 2026Locations: 1
Eligibility criteria

Written informed consent/assent of the patient or their legal representative/par... [+2]

Patients receiving Ilaris treatment for autoimmune disease other than CAPS, crFM... [+1]

Read more
Status: Recruiting

Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyrin-Associated Periodic Syndrome (CAPS)

This study will evaluate the efficacy, safety, tolerability and pharmacokinetics of JTE-162 administered once daily for 2 weeks in subjects with cryopyrin-associated periodic syndrome (CAPS)

Participants needed: 5
Trial details
Phase: Phase 1Age: 18-80Biological sex: AllType: InterventionalSponsor: Akros Pharma Inc.Updated: Feb 9, 2026Locations: 1
Eligibility criteria

Clinical History: At least 2 typical clinical symptoms (e.g., urticarial skin ra... [+3]

Has chronic infantile neurologic cutaneous articular syndrome (CINCA)/neonatal-o... [+2]

Read more